Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Odonate Therapeutics Inc (ODT)

Odonate Therapeutics Inc (ODT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 115,500
  • Shares Outstanding, K 38,500
  • Annual Sales, $ 0 K
  • Annual Income, $ -126,350 K
  • 60-Month Beta 0.33
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.53
Trade ODT with:

Options Overview

Details
  • Implied Volatility 81.46%
  • Historical Volatility 46.47%
  • IV Percentile 12%
  • IV Rank 17.88%
  • IV High 176.64% on 04/07/21
  • IV Low 60.75% on 08/19/21
  • Put/Call Vol Ratio 0.05
  • Today's Volume 65
  • Volume Avg (30-Day) 132
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 3,834
  • Open Int (30-Day) 1,830

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.93
  • Growth Rate Est. (year over year) +107,519.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.92 +2.74%
on 08/20/21
3.54 -15.25%
on 09/01/21
-0.03 (-0.99%)
since 08/17/21
3-Month
2.90 +3.45%
on 08/17/21
4.09 -26.65%
on 07/06/21
-0.61 (-16.90%)
since 06/17/21
52-Week
2.80 +7.14%
on 05/14/21
7.10 -57.76%
on 02/08/21
-0.69 (-18.75%)
since 09/17/20

Most Recent Stories

More News
SHAREHOLDER ALERT: Morris Kandinov Investigating ODT, AYTU, EAR, and CORT; Shareholders are Encouraged to Contact the Firm

National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Odonate Therapeutics, Inc., Aytu Biopharma, Inc., Eargo, Inc., and Corcept Therapeutics, Inc. ...

ODT : 3.00 (-6.54%)
AYTU : 3.13 (+3.30%)
EAR : 21.97 (+0.92%)
CORT : 20.51 (-0.58%)
SHAREHOLDER ALERT: Odonate Therapeutics, Inc. (ODT) Officers and Directors Under Investigation for Possible False Statements to Investors

/PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Odonate Therapeutics, Inc. (NASDAQ: ODT) relating to possible false statements to...

ODT : 3.00 (-6.54%)
Thinking about buying stock in Bridgeline Digital, Odonate Therapeutics, IVERIC bio, Ocugen, or Unity Biotechnology?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BLIN, ODT, ISEE, OCGN, and UBX.

BLIN : 4.40 (+0.69%)
ISEE : 16.62 (+1.59%)
OCGN : 7.93 (+5.17%)
ODT : 3.00 (-6.54%)
UBX : 3.03 (+2.02%)
Odonate Therapeutics (ODT) Enters Oversold Territory

Odonate Therapeutics (ODT) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock

ODT : 3.00 (-6.54%)
Odonate Therapeutics (ODT) is Oversold: Can It Recover?

Odonate Therapeutics (ODT) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

ODT : 3.00 (-6.54%)
Do Options Traders Know Something About Odonate Therapeutics (ODT) Stock We Don't?

Investors need to pay close attention to Odonate Therapeutics (ODT) stock based on the movements in the options market lately.

ODT : 3.00 (-6.54%)
Thinking about buying stock in Gevo Inc, Inovio Pharmaceuticals, Odonate Therapeutics, Cocrystal Pharma, or Vuzix Corp?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GEVO, INO, ODT, COCP, and VUZI.

COCP : 1.0500 (-2.78%)
INO : 8.14 (+5.03%)
ODT : 3.00 (-6.54%)
GEVO : 6.70 (+0.30%)
VUZI : 11.73 (-0.85%)
BeyondSpring Announces the Appointment of Dr. Jeffrey Vacirca to its Board of Directors

BeyondSpring (the "Company" or "BeyondSpring") (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced the appointment of Dr. Jeffrey...

BYSI : 22.91 (+1.78%)
ODT : 3.00 (-6.54%)
SPPI : 2.43 (+4.29%)
Lawsuits Filed Against ODT, GOCO and ICPT - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / November 16, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

ODT : 3.00 (-6.54%)
GOCO : 5.37 (-1.29%)
ICPT : 15.93 (+3.37%)
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PT, ODT and BMRN

NEW YORK, NY / ACCESSWIRE / November 16, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....

PT : 0.9261 (-1.48%)
ODT : 3.00 (-6.54%)
BMRN : 77.76 (+1.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Odonate Therapeutics, LLC is a pharmaceutical company. It engaged in the development of therapeutics to improve and extend the lives of patients with cancer. The company focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients with metastatic...

See More

Key Turning Points

3rd Resistance Point 3.48
2nd Resistance Point 3.39
1st Resistance Point 3.19
Last Price 3.00
1st Support Level 2.90
2nd Support Level 2.81
3rd Support Level 2.61

See More

52-Week High 7.10
Fibonacci 61.8% 5.46
Fibonacci 50% 4.95
Fibonacci 38.2% 4.44
Last Price 3.00
52-Week Low 2.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar